Ny Sin

Professor Ny Sin is an influential figure in the field of medicinal chemistry, whose innovative work continues to shape the landscape of neurodegenerative disease research. As an Associate Adjunct Professor in the Department of Neurology at the University of California, San Francisco, Dr. Sin brings a wealth of experience and expertise to his role. His academic journey began with a PhD in organic chemistry from Syracuse University, followed by a prestigious postdoctoral fellowship at Yale University, where he honed his skills in advanced chemical synthesis and drug development. Dr. Sin's professional career is marked by over 17 years of dedicated research and development at Bristol-Myers Squibb. During his tenure there, he made significant contributions to the field of medicinal chemistry, particularly in the development of HIV maturation inhibitors. His work in this area not only advanced scientific understanding but also contributed to the creation of new therapeutic options for patients. At UCSF, Dr. Sin's research is primarily focused on the synthesis of small molecules aimed at developing treatments for neurodegenerative diseases. His work is driven by a passion for discovering novel compounds that can potentially alter the course of debilitating conditions such as Alzheimer's and Parkinson's diseases. By leveraging his extensive background in organic chemistry and drug development, Dr. Sin is at the forefront of efforts to translate basic scientific discoveries into viable clinical therapies. In addition to his research, Dr. Sin is deeply committed to mentoring the next generation of scientists. He actively engages with students and postdoctoral fellows, providing guidance and fostering an environment of curiosity and innovation. His dedication to education and research excellence has made him a respected and admired member of the UCSF community. Dr. Sin's contributions to the field have been recognized through numerous awards and publications in leading scientific journals. His work not only exemplifies the integration of chemistry and neurology but also underscores the importance of interdisciplinary approaches in tackling complex medical challenges. As he continues to explore new frontiers in neurodegenerative disease research, Dr. Sin remains a pivotal figure in the quest for groundbreaking treatments that can improve the quality of life for countless individuals.